Huperzine A provides seizure protection in genetic epilepsy models
Researchers discovered huperzine A increases resistance to induced seizures in mouse models of genetic epilepsy. The compound has been shown to protect against febrile seizures, a feature of both Dravet syndrome and GEFS+, with complete protection observed in genetically modified mice.